Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022693640> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W2022693640 endingPage "S51" @default.
- W2022693640 startingPage "S47" @default.
- W2022693640 abstract "<h2>Abstract</h2> We studied, in healthy subjects (<i>n</i>=4) and in non-insulin-dependent diabetics (<i>n</i>=4), the effect of a new sulfonylurea, Diamicron<sup>®</sup>, on the secretion and action of insulin, using a mathematical model. This model analyzed, during an intravenous glucose tolerance test, the response of the first and second phase of insulin secretion in relation to the variations in blood glucose (insulin secretion) and the rate of decline in the blood glucose curve in relation to the variations in insulin (insulin response). Each subject was studied twice: once after administration of placebo and once after administration of Diamicron<sup>®</sup> 80 mg 90 min after intravenous injection of 300 mg/kg of d-glucose. In healthy subjects, the glucose load after placebo induced an insulin response of 7.4 ± 1.0 and 11.3 ± 1.4 μU ml<sup>−1</sup> min<sup>−1</sup> mg<sup>−1</sup> dl<sup>−1</sup> for the first and second phases, respectively, and an insulin sensitivity evaluated to be 4.7 ± 0.3 min μU<sup>−1</sup> ml<sup>−1</sup>. Following the administration of Diamicron<sup>®</sup>, the insulin response to the same glucose load increased two-fold and five-fold for the first and second phases, respectively, and the insulin sensitivity also increased by a factor of 2. In diabetic subjects the insulin response to the glucose load after placebo was markedly decreased (2.2 ± 0.5 and 2.5 ± 0.3 μU ml<sup>−1</sup> min<sup>−1</sup> mg<sup>−1</sup> dl<sup>−1</sup>, respectively) as was the insulin sensitivity (2.5 ± 0.3 min μU<sup>−1</sup> ml<sup>−1</sup>). The administration of Diamicron<sup>®</sup> increased all these parameters by a factor of 2. These findings indicate that in healthy subjects and non-insulin-dependent diabetics, Diamicron<sup>®</sup> is a potent hypoglycemic agent which acts by increasing the first and second phase of insulin secretion and by increasing the sensitivity to insulin." @default.
- W2022693640 created "2016-06-24" @default.
- W2022693640 creator A5017669845 @default.
- W2022693640 creator A5025572908 @default.
- W2022693640 creator A5030204161 @default.
- W2022693640 date "1991-01-01" @default.
- W2022693640 modified "2023-10-01" @default.
- W2022693640 title "The effect of Diamicron® on the secretion and action of insulin" @default.
- W2022693640 cites W1566830427 @default.
- W2022693640 cites W1974540301 @default.
- W2022693640 cites W1977797609 @default.
- W2022693640 cites W1987313581 @default.
- W2022693640 cites W2028520749 @default.
- W2022693640 cites W2031820400 @default.
- W2022693640 cites W2048109379 @default.
- W2022693640 cites W2054293703 @default.
- W2022693640 cites W2119891717 @default.
- W2022693640 cites W2125389684 @default.
- W2022693640 cites W2156353972 @default.
- W2022693640 cites W2397640844 @default.
- W2022693640 doi "https://doi.org/10.1016/0168-8227(91)90007-z" @default.
- W2022693640 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1794265" @default.
- W2022693640 hasPublicationYear "1991" @default.
- W2022693640 type Work @default.
- W2022693640 sameAs 2022693640 @default.
- W2022693640 citedByCount "19" @default.
- W2022693640 countsByYear W20226936402013 @default.
- W2022693640 countsByYear W20226936402019 @default.
- W2022693640 crossrefType "journal-article" @default.
- W2022693640 hasAuthorship W2022693640A5017669845 @default.
- W2022693640 hasAuthorship W2022693640A5025572908 @default.
- W2022693640 hasAuthorship W2022693640A5030204161 @default.
- W2022693640 hasConcept C126322002 @default.
- W2022693640 hasConcept C134018914 @default.
- W2022693640 hasConcept C2777391703 @default.
- W2022693640 hasConcept C2779306644 @default.
- W2022693640 hasConcept C2780352109 @default.
- W2022693640 hasConcept C555293320 @default.
- W2022693640 hasConcept C71924100 @default.
- W2022693640 hasConceptScore W2022693640C126322002 @default.
- W2022693640 hasConceptScore W2022693640C134018914 @default.
- W2022693640 hasConceptScore W2022693640C2777391703 @default.
- W2022693640 hasConceptScore W2022693640C2779306644 @default.
- W2022693640 hasConceptScore W2022693640C2780352109 @default.
- W2022693640 hasConceptScore W2022693640C555293320 @default.
- W2022693640 hasConceptScore W2022693640C71924100 @default.
- W2022693640 hasLocation W20226936401 @default.
- W2022693640 hasLocation W20226936402 @default.
- W2022693640 hasOpenAccess W2022693640 @default.
- W2022693640 hasPrimaryLocation W20226936401 @default.
- W2022693640 hasRelatedWork W1967954429 @default.
- W2022693640 hasRelatedWork W2000308085 @default.
- W2022693640 hasRelatedWork W2001044066 @default.
- W2022693640 hasRelatedWork W2011317531 @default.
- W2022693640 hasRelatedWork W2029049751 @default.
- W2022693640 hasRelatedWork W2033840628 @default.
- W2022693640 hasRelatedWork W2056849036 @default.
- W2022693640 hasRelatedWork W2089387278 @default.
- W2022693640 hasRelatedWork W2095179743 @default.
- W2022693640 hasRelatedWork W2124070488 @default.
- W2022693640 hasVolume "14" @default.
- W2022693640 isParatext "false" @default.
- W2022693640 isRetracted "false" @default.
- W2022693640 magId "2022693640" @default.
- W2022693640 workType "article" @default.